1 | maintained | 7,460 |
2 | kept | 1,444 |
3 | worn | 321 |
4 | alternated | 96 |
5 | equalized | 38 |
6 | recouped | 5 |
7 | drip-infused | 4 |
8 | transfixed | 4 |
9 | cotreatments | 3 |
10 | splashed | 3 |
11 | 'rales | 2 |
12 | -17.58 | 2 |
13 | 2-aminoprop-1-ene-1,1,3-tricarbonitrile | 2 |
14 | amortized | 2 |
15 | choked | 2 |
16 | cobedded | 2 |
17 | immunoselected | 2 |
18 | kneaded | 2 |
19 | ldl-lipoproteins | 2 |
20 | post-hiped | 2 |
21 | significantpain | 2 |
22 | sub-cultured | 2 |
23 | ventured | 2 |
24 | ≤-1.0 | 2 |
25 | +3.00d | 1 |
26 | -0.24-0.63 | 1 |
27 | -13mmhg | 1 |
28 | 0.05±0.002 | 1 |
29 | 0.44/0.08 | 1 |
30 | 0.50+/-0.32 | 1 |
31 | 0.547±0.032 | 1 |
32 | 0.7-3 | 1 |
33 | 0.74±0.11 | 1 |
34 | 0.81±0.17 | 1 |
35 | 1,613±495 | 1 |
36 | 1.07°c | 1 |
37 | 1.9±1.9°c | 1 |
38 | 10.5+/-2.1 | 1 |
39 | 102.8mg/dl | 1 |
40 | 107.2+17 | 1 |
41 | 123º | 1 |
42 | 130.0du/mg | 1 |
43 | 149/93 | 1 |
44 | 162°c | 1 |
45 | 189.8±22.6 | 1 |
46 | 19.1° | 1 |
47 | 1:0.95:0.89 | 1 |
48 | 2-methoxypropene | 1 |
49 | 2.56+/-0.42 | 1 |
50 | 2.78+/-0.43 | 1 |
51 | 23.8+/-5.0 | 1 |
52 | 23.8-33.7mm | 1 |
53 | 23:3 | 1 |
54 | 25.30±3.40 | 1 |
55 | 27.5+/-26.4 | 1 |
56 | 3.53h | 1 |
57 | 3.7+/-2.6 | 1 |
58 | 33,480 | 1 |
59 | 33days | 1 |
60 | 35.5u/l | 1 |
61 | 370-mg/ml | 1 |
62 | 4.5/1000 | 1 |
63 | 5.17±0.27 | 1 |
64 | 5.8t/ha | 1 |
65 | 6.75° | 1 |
66 | 600ppm | 1 |
67 | 67/79 | 1 |
68 | 7,03 | 1 |
69 | 7.9°c/w | 1 |
70 | 77+ | 1 |
71 | 79.8±5.9 | 1 |
72 | 8-deoxygartanine | 1 |
73 | 8.48° | 1 |
74 | 8.5±1.7 | 1 |
75 | 80.7±22.1 | 1 |
76 | 83+/-17kg | 1 |
77 | 91.4°c | 1 |
78 | 97.8±1.2 | 1 |
79 | angiectasia | 1 |
80 | animosities | 1 |
81 | anteriory | 1 |
82 | arc124910xx | 1 |
83 | athsp | 1 |
84 | audio-diaries | 1 |
85 | behavior-and | 1 |
86 | c-derivatives | 1 |
87 | cd-pb | 1 |
88 | cide-c | 1 |
89 | clinically/anamnestically | 1 |
90 | cost/qaly-gains | 1 |
91 | d2o/dmso | 1 |
92 | days-postpartum | 1 |
93 | dd-homozygous | 1 |
94 | desmethyl-rr | 1 |
95 | dimethyllysines | 1 |
96 | drug-adherence | 1 |
97 | ed1a | 1 |
98 | end-systolic-volume | 1 |
99 | enstatite | 1 |
100 | faith/spirituality | 1 |
101 | farmer-treated | 1 |
102 | follow-up/2 | 1 |
103 | fungi/bacteria | 1 |
104 | glided | 1 |
105 | glucotriose | 1 |
106 | glycerol-2-phosphate | 1 |
107 | guanylation | 1 |
108 | hyper-osmotically | 1 |
109 | hypoosmolality | 1 |
110 | insonified | 1 |
111 | jeering | 1 |
112 | jenoclean | 1 |
113 | kalisz | 1 |
114 | kc-like | 1 |
115 | menqof | 1 |
116 | methyliodide | 1 |
117 | missingnessprocesses | 1 |
118 | mobility-function | 1 |
119 | myxopyronin | 1 |
120 | nct00265330 | 1 |
121 | nct00265382 | 1 |
122 | nitriloacetate | 1 |
123 | normally-distributed | 1 |
124 | overreactive | 1 |
125 | p103 | 1 |
126 | panmixia | 1 |
127 | paracetamol-meperidine | 1 |
128 | parent/guardians | 1 |
129 | pbvs | 1 |
130 | pcl5 | 1 |
131 | pha-m | 1 |
132 | pnpo | 1 |
133 | polyoxytetramethylenediol | 1 |
134 | postfilter/oxygenator | 1 |
135 | pr3-anca-positive | 1 |
136 | prebf | 1 |
137 | preventable.• | 1 |
138 | protective/harmful | 1 |
139 | rehydrogenation | 1 |
140 | rs17651822 | 1 |
141 | rs2290203 | 1 |
142 | second-graders | 1 |
143 | self-maintain | 1 |
144 | shgb | 1 |
145 | stoped | 1 |
146 | t-ba | 1 |
147 | thse | 1 |
148 | tided | 1 |
149 | under-activity | 1 |
150 | were:142±31 | 1 |
151 | xylene/ethylbenzene | 1 |
152 | δapoe | 1 |
153 | €272,293,182.85 | 1 |
154 | €424,542 | 1 |
155 | ≥722 | 1 |
1 | 'rales | 2 |
2 | +3.00d | 1 |
3 | -0.24-0.63 | 1 |
4 | -13mmhg | 1 |
5 | -17.58 | 2 |
6 | 0.05±0.002 | 1 |
7 | 0.44/0.08 | 1 |
8 | 0.50+/-0.32 | 1 |
9 | 0.547±0.032 | 1 |
10 | 0.7-3 | 1 |
11 | 0.74±0.11 | 1 |
12 | 0.81±0.17 | 1 |
13 | 1,613±495 | 1 |
14 | 1.07°c | 1 |
15 | 1.9±1.9°c | 1 |
16 | 10.5+/-2.1 | 1 |
17 | 102.8mg/dl | 1 |
18 | 107.2+17 | 1 |
19 | 123º | 1 |
20 | 130.0du/mg | 1 |
21 | 149/93 | 1 |
22 | 162°c | 1 |
23 | 189.8±22.6 | 1 |
24 | 19.1° | 1 |
25 | 1:0.95:0.89 | 1 |
26 | 2-aminoprop-1-ene-1,1,3-tricarbonitrile | 2 |
27 | 2-methoxypropene | 1 |
28 | 2.56+/-0.42 | 1 |
29 | 2.78+/-0.43 | 1 |
30 | 23.8+/-5.0 | 1 |
31 | 23.8-33.7mm | 1 |
32 | 23:3 | 1 |
33 | 25.30±3.40 | 1 |
34 | 27.5+/-26.4 | 1 |
35 | 3.53h | 1 |
36 | 3.7+/-2.6 | 1 |
37 | 33,480 | 1 |
38 | 33days | 1 |
39 | 35.5u/l | 1 |
40 | 370-mg/ml | 1 |
41 | 4.5/1000 | 1 |
42 | 5.17±0.27 | 1 |
43 | 5.8t/ha | 1 |
44 | 6.75° | 1 |
45 | 600ppm | 1 |
46 | 67/79 | 1 |
47 | 7,03 | 1 |
48 | 7.9°c/w | 1 |
49 | 77+ | 1 |
50 | 79.8±5.9 | 1 |
51 | 8-deoxygartanine | 1 |
52 | 8.48° | 1 |
53 | 8.5±1.7 | 1 |
54 | 80.7±22.1 | 1 |
55 | 83+/-17kg | 1 |
56 | 91.4°c | 1 |
57 | 97.8±1.2 | 1 |
58 | alternated | 96 |
59 | amortized | 2 |
60 | angiectasia | 1 |
61 | animosities | 1 |
62 | anteriory | 1 |
63 | arc124910xx | 1 |
64 | athsp | 1 |
65 | audio-diaries | 1 |
66 | behavior-and | 1 |
67 | c-derivatives | 1 |
68 | cd-pb | 1 |
69 | choked | 2 |
70 | cide-c | 1 |
71 | clinically/anamnestically | 1 |
72 | cobedded | 2 |
73 | cost/qaly-gains | 1 |
74 | cotreatments | 3 |
75 | d2o/dmso | 1 |
76 | days-postpartum | 1 |
77 | dd-homozygous | 1 |
78 | desmethyl-rr | 1 |
79 | dimethyllysines | 1 |
80 | drip-infused | 4 |
81 | drug-adherence | 1 |
82 | ed1a | 1 |
83 | end-systolic-volume | 1 |
84 | enstatite | 1 |
85 | equalized | 38 |
86 | faith/spirituality | 1 |
87 | farmer-treated | 1 |
88 | follow-up/2 | 1 |
89 | fungi/bacteria | 1 |
90 | glided | 1 |
91 | glucotriose | 1 |
92 | glycerol-2-phosphate | 1 |
93 | guanylation | 1 |
94 | hyper-osmotically | 1 |
95 | hypoosmolality | 1 |
96 | immunoselected | 2 |
97 | insonified | 1 |
98 | jeering | 1 |
99 | jenoclean | 1 |
100 | kalisz | 1 |
101 | kc-like | 1 |
102 | kept | 1,444 |
103 | kneaded | 2 |
104 | ldl-lipoproteins | 2 |
105 | maintained | 7,460 |
106 | menqof | 1 |
107 | methyliodide | 1 |
108 | missingnessprocesses | 1 |
109 | mobility-function | 1 |
110 | myxopyronin | 1 |
111 | nct00265330 | 1 |
112 | nct00265382 | 1 |
113 | nitriloacetate | 1 |
114 | normally-distributed | 1 |
115 | overreactive | 1 |
116 | p103 | 1 |
117 | panmixia | 1 |
118 | paracetamol-meperidine | 1 |
119 | parent/guardians | 1 |
120 | pbvs | 1 |
121 | pcl5 | 1 |
122 | pha-m | 1 |
123 | pnpo | 1 |
124 | polyoxytetramethylenediol | 1 |
125 | post-hiped | 2 |
126 | postfilter/oxygenator | 1 |
127 | pr3-anca-positive | 1 |
128 | prebf | 1 |
129 | preventable.• | 1 |
130 | protective/harmful | 1 |
131 | recouped | 5 |
132 | rehydrogenation | 1 |
133 | rs17651822 | 1 |
134 | rs2290203 | 1 |
135 | second-graders | 1 |
136 | self-maintain | 1 |
137 | shgb | 1 |
138 | significantpain | 2 |
139 | splashed | 3 |
140 | stoped | 1 |
141 | sub-cultured | 2 |
142 | t-ba | 1 |
143 | thse | 1 |
144 | tided | 1 |
145 | transfixed | 4 |
146 | under-activity | 1 |
147 | ventured | 2 |
148 | were:142±31 | 1 |
149 | worn | 321 |
150 | xylene/ethylbenzene | 1 |
151 | δapoe | 1 |
152 | €272,293,182.85 | 1 |
153 | €424,542 | 1 |
154 | ≤-1.0 | 2 |
155 | ≥722 | 1 |
1 | 77+ | 1 |
2 | ≤-1.0 | 2 |
3 | 23.8+/-5.0 | 1 |
4 | 4.5/1000 | 1 |
5 | nct00265330 | 1 |
6 | 25.30±3.40 | 1 |
7 | 33,480 | 1 |
8 | 10.5+/-2.1 | 1 |
9 | 80.7±22.1 | 1 |
10 | 0.74±0.11 | 1 |
11 | were:142±31 | 1 |
12 | 97.8±1.2 | 1 |
13 | follow-up/2 | 1 |
14 | 0.05±0.002 | 1 |
15 | ≥722 | 1 |
16 | rs17651822 | 1 |
17 | 0.50+/-0.32 | 1 |
18 | 0.547±0.032 | 1 |
19 | 2.56+/-0.42 | 1 |
20 | €424,542 | 1 |
21 | nct00265382 | 1 |
22 | 0.7-3 | 1 |
23 | 7,03 | 1 |
24 | p103 | 1 |
25 | rs2290203 | 1 |
26 | 2.78+/-0.43 | 1 |
27 | -0.24-0.63 | 1 |
28 | 149/93 | 1 |
29 | 23:3 | 1 |
30 | 27.5+/-26.4 | 1 |
31 | €272,293,182.85 | 1 |
32 | 1,613±495 | 1 |
33 | pcl5 | 1 |
34 | 3.7+/-2.6 | 1 |
35 | 189.8±22.6 | 1 |
36 | 8.5±1.7 | 1 |
37 | 107.2+17 | 1 |
38 | 0.81±0.17 | 1 |
39 | 5.17±0.27 | 1 |
40 | 0.44/0.08 | 1 |
41 | -17.58 | 2 |
42 | 79.8±5.9 | 1 |
43 | 67/79 | 1 |
44 | 1:0.95:0.89 | 1 |
45 | ed1a | 1 |
46 | t-ba | 1 |
47 | 5.8t/ha | 1 |
48 | fungi/bacteria | 1 |
49 | angiectasia | 1 |
50 | panmixia | 1 |
51 | shgb | 1 |
52 | cd-pb | 1 |
53 | cide-c | 1 |
54 | 162°c | 1 |
55 | 91.4°c | 1 |
56 | 1.07°c | 1 |
57 | 1.9±1.9°c | 1 |
58 | +3.00d | 1 |
59 | kneaded | 2 |
60 | cobedded | 2 |
61 | glided | 1 |
62 | tided | 1 |
63 | splashed | 3 |
64 | insonified | 1 |
65 | choked | 2 |
66 | maintained | 7,460 |
67 | post-hiped | 2 |
68 | stoped | 1 |
69 | recouped | 5 |
70 | sub-cultured | 2 |
71 | ventured | 2 |
72 | drip-infused | 4 |
73 | farmer-treated | 1 |
74 | alternated | 96 |
75 | immunoselected | 2 |
76 | normally-distributed | 1 |
77 | transfixed | 4 |
78 | equalized | 38 |
79 | amortized | 2 |
80 | behavior-and | 1 |
81 | drug-adherence | 1 |
82 | methyliodide | 1 |
83 | kc-like | 1 |
84 | 2-aminoprop-1-ene-1,1,3-tricarbonitrile | 2 |
85 | end-systolic-volume | 1 |
86 | 2-methoxypropene | 1 |
87 | xylene/ethylbenzene | 1 |
88 | paracetamol-meperidine | 1 |
89 | 8-deoxygartanine | 1 |
90 | δapoe | 1 |
91 | thse | 1 |
92 | glucotriose | 1 |
93 | glycerol-2-phosphate | 1 |
94 | nitriloacetate | 1 |
95 | enstatite | 1 |
96 | overreactive | 1 |
97 | pr3-anca-positive | 1 |
98 | prebf | 1 |
99 | menqof | 1 |
100 | -13mmhg | 1 |
101 | 83+/-17kg | 1 |
102 | 130.0du/mg | 1 |
103 | jeering | 1 |
104 | 3.53h | 1 |
105 | 35.5u/l | 1 |
106 | 102.8mg/dl | 1 |
107 | 370-mg/ml | 1 |
108 | polyoxytetramethylenediol | 1 |
109 | protective/harmful | 1 |
110 | pha-m | 1 |
111 | 23.8-33.7mm | 1 |
112 | 600ppm | 1 |
113 | days-postpartum | 1 |
114 | jenoclean | 1 |
115 | significantpain | 2 |
116 | self-maintain | 1 |
117 | myxopyronin | 1 |
118 | guanylation | 1 |
119 | rehydrogenation | 1 |
120 | mobility-function | 1 |
121 | worn | 321 |
122 | pnpo | 1 |
123 | d2o/dmso | 1 |
124 | athsp | 1 |
125 | postfilter/oxygenator | 1 |
126 | desmethyl-rr | 1 |
127 | audio-diaries | 1 |
128 | animosities | 1 |
129 | 'rales | 2 |
130 | dimethyllysines | 1 |
131 | missingnessprocesses | 1 |
132 | c-derivatives | 1 |
133 | parent/guardians | 1 |
134 | cost/qaly-gains | 1 |
135 | ldl-lipoproteins | 2 |
136 | second-graders | 1 |
137 | cotreatments | 3 |
138 | dd-homozygous | 1 |
139 | pbvs | 1 |
140 | 33days | 1 |
141 | kept | 1,444 |
142 | 7.9°c/w | 1 |
143 | arc124910xx | 1 |
144 | hyper-osmotically | 1 |
145 | clinically/anamnestically | 1 |
146 | anteriory | 1 |
147 | hypoosmolality | 1 |
148 | faith/spirituality | 1 |
149 | under-activity | 1 |
150 | kalisz | 1 |
151 | preventable.• | 1 |
152 | 19.1° | 1 |
153 | 6.75° | 1 |
154 | 8.48° | 1 |
155 | 123º | 1 |